Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




Key Protein May Help to Repair Damaged DNA

By LabMedica International staff writers
Posted on 20 Jan 2010
To preserve a person's DNA, cells have developed a complex system for monitoring and repairing DNA damage. More...
Yet, exactly how the first damage signal is converted into a repair response remains unclear. Researchers have now solved a crucial piece of the complex puzzle.

In an article published in the December 24, 2009, issue of the journal Molecular Cell, investigators from the Salk Institute for Biological Studies (La Jolla, CA, USA) demonstrated that a protein named CtIP plays a fundamental role in the DNA damage "signal-to-repair” conversion process. "Being able to repair damaged DNA is extremely important; the cell has to know when it has received this type of damage and respond appropriately,” explained Tony Hunter, Ph.D., a professor in the Molecular and Cell Biology Laboratory and director of the Salk Institute Cancer Center, who led the study. "Failure to do so can have disastrous consequences.”

The DNA in an organism's cells is under constant attack from reactive chemicals generated as byproducts of cellular metabolism. Moreover, it is battered by X-rays, ultraviolet radiation from the sun, and environmental carcinogens such as tobacco smoke. Because of this continuous assault, some studies have estimated that the DNA in a single human cell is damaged over 10,000 times every day.

If not repaired correctly, the damage leads to mutations, which over time can cause cancer. "As a result, individuals with an inherited impairment in DNA repair capability are often at increased risk of cancer,” noted first author Zhongsheng You, Ph.D., a former postdoctoral researcher at the Salk Institute and now an assistant professor at Washington University School of Medicine in St. Louis (MO, USA).

DNA consists of two intertwined strands so that when the DNA is broken, two ends are revealed, one from each strand. In order to repair the DNA break, one strand is trimmed away--or resected--similar to a loose thread, leaving only the second strand. This exposed strand then searches for a copy of itself (located on its sister chromosome), and "photocopies” past the broken region, repairing the DNA, and zipping itself back up.

In yeast, CtIP is required for resection of the broken end, and since it is also recruited to sites of DNA damage in human cells, Dr. Hunter's team wanted to figure out whether CtIP plays a similar role there. To find out, they depleted CtIP from human cells and caused DNA damage. Without the CtIP, they discovered, the cells could no longer trim back the damaged DNA strands, which brought the whole repair process to an abrupt halt.

"It looks like CtIP recruitment is a very important control point in the DNA repair process,” Dr. You observed. "Once CtIP is recruited, resection and repair begin, so regulating CtIP recruitment is one way to regulate DNA repair itself.”

In order to understand the process better, the researchers then tried to find out which regions of the CtIP protein are involved in binding it to the broken DNA ends. By looking at small portions of the protein, they found that a region in the central part of CtIP helps recruit the protein. They named this region the "damage recruitment” (DR) domain.

Further studies suggested that the DR domain within CtIP is typically hidden inside the folded protein. Only when the cell sends a DNA damage signal is CtIP's DR domain exposed, and only then can CtIP bind to the broken DNA. In this way, CtIP is like a switchblade that cells open only in the presence of DNA damage.

The scientists believe that exposure of CtIP's DR domain and its recruitment to the site of DNA damage starts a chain reaction that results in DNA repair, and they now want to understand precisely what CtIP does to start the DNA repair process.

Dr. You is also trying to understand the modifications in CtIP that cause the DR domain to be exposed, and is looking into the role of CtIP in cancer. "Mutations in CtIP have not been mapped extensively in human tumors, but from this data, we predict that mutations to the DR domain would lead to cancer,” he commented.

In the long term, the investigators hope that a better understanding of the DNA damage pathway may provide clues for cancer treatment in the future. "CtIP is another important player in the double-strand break response,” stated Dr. Hunter. "We have added another piece to the complex puzzle of DNA repair.”

Related Links:

Salk Institute for Biological Studies




Gold Member
Quality Control Material
iPLEX Pro Exome QC Panel
POC Helicobacter Pylori Test Kit
Hepy Urease Test
Gel Cards
DG Gel Cards
Sample Transportation System
Tempus1800 Necto
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Molecular Diagnostics

view channel
Image: The diagnostic device can tell how deadly brain tumors respond to treatment from a simple blood test (Photo courtesy of UQ)

Diagnostic Device Predicts Treatment Response for Brain Tumors Via Blood Test

Glioblastoma is one of the deadliest forms of brain cancer, largely because doctors have no reliable way to determine whether treatments are working in real time. Assessing therapeutic response currently... Read more

Immunology

view channel
Image: Circulating tumor cells isolated from blood samples could help guide immunotherapy decisions (Photo courtesy of Shutterstock)

Blood Test Identifies Lung Cancer Patients Who Can Benefit from Immunotherapy Drug

Small cell lung cancer (SCLC) is an aggressive disease with limited treatment options, and even newly approved immunotherapies do not benefit all patients. While immunotherapy can extend survival for some,... Read more

Microbiology

view channel
Image: New evidence suggests that imbalances in the gut microbiome may contribute to the onset and progression of MCI and Alzheimer’s disease (Photo courtesy of Adobe Stock)

Comprehensive Review Identifies Gut Microbiome Signatures Associated With Alzheimer’s Disease

Alzheimer’s disease affects approximately 6.7 million people in the United States and nearly 50 million worldwide, yet early cognitive decline remains difficult to characterize. Increasing evidence suggests... Read more

Technology

view channel
Image: Vitestro has shared a detailed visual explanation of its Autonomous Robotic Phlebotomy Device (photo courtesy of Vitestro)

Robotic Technology Unveiled for Automated Diagnostic Blood Draws

Routine diagnostic blood collection is a high‑volume task that can strain staffing and introduce human‑dependent variability, with downstream implications for sample quality and patient experience.... Read more

Industry

view channel
Image: Roche’s cobas® Mass Spec solution enables fully automated mass spectrometry in routine clinical laboratories (Photo courtesy of Roche)

New Collaboration Brings Automated Mass Spectrometry to Routine Laboratory Testing

Mass spectrometry is a powerful analytical technique that identifies and quantifies molecules based on their mass and electrical charge. Its high selectivity, sensitivity, and accuracy make it indispensable... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.